JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

The FIGHT-RP1 Study

Phase 1

Completed

Conditions: Retinitis Pigmentosa

Interventions: Drug: N-Acetyl Cysteine (NAC)

First Posted Date: 2017-02-24

Last Posted Date: 2022-09-19

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT03063021

Locations: 🇺🇸
Wilmer Eye Institute, Johns Hopkins, Baltimore, Maryland, United States

Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women

Phase 1

Completed

Conditions: HIV Prevention

Interventions: Drug: Tenofovir Disoproxil Fumarate/Emtricitabine

First Posted Date: 2017-02-23

Last Posted Date: 2018-07-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 16

Registration Number: NCT03060785

Locations: 🇺🇸
Johns Hopkins University Drug Development Unit, Baltimore, Maryland, United States

Trial of Orencia in Patients With Myasthenia Gravis

Early Phase 1

Terminated

Conditions: Myasthenia Gravis

Interventions: Drug: Abatacept Injection

First Posted Date: 2017-02-23

Last Posted Date: 2019-11-22

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 6

Registration Number: NCT03059888

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus

Phase 4

Withdrawn

Conditions: Neonatal Post-Hemorrhagic Hydrocephalus

Interventions: Drug: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]

First Posted Date: 2017-02-23

Last Posted Date: 2018-01-25

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03061045

SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD

Not Applicable

Completed

Conditions: Social Behavior
ESRD
Physical Disability

Interventions: Behavioral: SOCIABLE

First Posted Date: 2017-02-16

Last Posted Date: 2017-08-21

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 12

Registration Number: NCT03055273

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Propranolol for Sleep Apnea Therapy

Phase 2

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Drug: Propranolol Oral Tablet
Drug: Placebo Oral Tablet

First Posted Date: 2017-02-10

Last Posted Date: 2024-05-20

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 23

Registration Number: NCT03049306

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Other: Paleolithic diet
Other: General Healthful Diet

First Posted Date: 2017-01-30

Last Posted Date: 2020-05-07

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 40

Registration Number: NCT03035799

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Community-Based Cervical Cancer Prevention and Education Among Women Living With HIV

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: Health-Literacy Focused Education Session

First Posted Date: 2017-01-27

Last Posted Date: 2020-06-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 123

Registration Number: NCT03033888

Locations: 🇺🇸
Johns Hopkins University School of Nursing, Baltimore, Maryland, United States

Microbiome of Urologic Chronic Pelvic Pain Syndrome

Withdrawn

Conditions: Chronic Prostatitis
Prostatitis
Interstitial Cystitis
Bladder Pain Syndrome
Painful Bladder Syndrome

Interventions: Procedure: Collect midstream urine samples
Procedure: Genitourinary Specimen Collection

First Posted Date: 2017-01-20

Last Posted Date: 2017-08-30

Lead Sponsor: Johns Hopkins University

Registration Number: NCT03027076

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

Not Applicable

Completed

Conditions: Adriamycin Toxicity
Breast Cancer Female

Interventions: Behavioral: 10,000 steps
Behavioral: Usual Care

First Posted Date: 2017-01-20

Last Posted Date: 2021-01-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 21

Registration Number: NCT03027063

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy